Physician profile
Steven M Thackeray
NPI 1407813959
$816.90
in general payments reported to CMS, 2019-2025
17 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $29.69 · 2021: $10.98 · 2022: $96.41 · 2023: $246 · 2024: $85.46 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $137.85 | 2022-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Hologic Sales and Service, LLC | $133.19 | 2019-2025 | Novasure, Omni Hysteroscope, Acessa Provu System |
| Organon LLC | $120.85 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $89.07 | 2020-2023 | Slynd |
| Medtronic, INC. | $58.79 | 2023 | Truclear |
| Bayer Healthcare Pharmaceuticals INC. | $48.12 | 2019-2020 | |
| Roche Diagnostics Corporation | $35.21 | 2019 | |
| Dexcom, INC. | $34.17 | 2025 | Dexcom G6 Transmitter |
| Allergan, INC. | $31.97 | 2019 | |
| Acessa Health INC. | $21.09 | 2019 | |
| Sumitomo Pharma America, INC. | $17.87 | 2025 | Myfembree |
| Duchesnay USA Incorporated | $17.50 | 2019 | |
| Biogen, INC. | $16.25 | 2024 | |
| Therapeuticsmd, INC. | $16.00 | 2019 | |
| Daiichi Sankyo INC. | $14.16 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $13.48 | 2023 | Accrufer |
| Minerva Surgical, INC | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Thackeray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.